• Home
  • The Biotech’s Guide for CDMO Selection

CPHI Webinar Series

The Biotech’s Guide for CDMO Selection

Watch Now
23rd March, 2023
4pm CET / 10am EST
What will this webinar address?

A continuous challenge that stands in our way is the ever-growing cost of bringing new drugs to market. This year, biopharma companies will continue their efforts to optimize the “total cost of ownership” associated with developing, manufacturing, and commercializing their products. This will lead to an increased focus on not just the function but also the value of outsourced partnerships.  

This has led to biopharma companies are looking for third-party experts who do more than fill an internal skill gapor enable an in-house team to focus on core competencies. These customers are increasingly looking for providers who deliver a strategic, value adding mix of specialized services, customized solutions, and efficient operations—one that spans as much of the value chain as possible.

Join our latest CPHI Webinar, where our experts will discuss the importance in choosing a CDMO and why is essential in getting it right the first time.


  • Identifying and assessing your current project needs and understand what you are looking for in a partner (e.g sourcing of raw material)
  • Why Pre-planning and continuous communication is essential to avoid any confusion or bottlenecks down the line
  • Evaluating common pitfalls and how to avoid them
  • Reviewing current trends in the market such as on or nearshoring and what that means for your potential partnership

Bill Connell
Principal and Supply Chain Practice Leader
Tunnell Consulting

Bill Connell brings over 30 years of experience to Tunnell Consulting with both consulting and pharmaceutical operations experience in Life Sciences in the areas of supply chain strategy and optimization, CDMO selection and management, operational excellence and technology solutions such as ERP implementation and validation. His leadership skills and specialized insights have consistently delivered positive results, operational improvements and improved client profitability and performance.

Phillip Coetzee
Director CMO Management
Daiichi Sankyo Europe

After working 9 years for a CMO as part of the Quote Team, Philip Coetzee has gained extensive experience on how CMOs operate. As Director CMO Management at Daiichi Sankyo, he can use this knowledge to ensure RFQs meet the needs of CMOs, as well as ensure that CMOs meet the DS requirements. His degrees in Analytical Chemistry and Business Management gives him the business foundation required to form long and lasting relationships with business partners.

Marazban Sarkari
Head, Cell & Gene Therapy QA
GSK
Marazban Sarkari, PhD, is Head of the Cell & Gene Therapy Quality Assurance group at GSK and manages their quality operations at multiple CMOs and internal sites. Previously, he led the CGT external quality assurance (QA) team at Iovance Biotherapeutics, helping build their quality systems and operations teams. He is a chemical engineer by training and has more than 20 years of experience in outsourced pharmaceutical drug product manufacturing, and formulation and analytical development covering both large and small molecules. His teams have been involved in vendor selection, contract negotiation, project management and process scale-up and optimization.
Stephanie Gaulding
Managing Director
Pharmatech Associates, Inc,
Ms. Gaulding serves as our Managing Director, bringing more than 25 years of experience in quality management systems and validation program management in Pharma, Biotech, Medical Device, and related life science industries. Drawing on her extensive background, Ms Gaulding develops and delivers efficient and sustainable quality management systems assuring compliance with global regulatory requirements and industry best practices.
Overview
The Biotech’s Guide for CDMO Selection
  • 23rd March, 2023
  • 4pm CET / 10am EST
  • 60 minutes
  • Free
Watch Now